Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate
Clinical trial NCT01046487 · COMPLETED
Trial details
- NCT number
- NCT01046487
- Sponsor
- Centre Oscar Lambret
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-09
- Primary completion
- 2011-04-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.